Suppr超能文献

编码颗粒微流控平台用于快速多重筛选和鉴定抗甲型流感核蛋白的适配体。

Encoded particle microfluidic platform for rapid multiplexed screening and characterization of aptamers against influenza A nucleoprotein.

机构信息

Department of Biosystems, Biosensors Group, KU Leuven, Willem de Croylaan 42, 3001, Leuven, Belgium.

Department of Biosystems, Biosensors Group, KU Leuven, Willem de Croylaan 42, 3001, Leuven, Belgium.

出版信息

Anal Chim Acta. 2019 Apr 11;1053:70-80. doi: 10.1016/j.aca.2018.11.055. Epub 2018 Dec 5.

Abstract

Aptamers represent interesting bioreceptor alternatives to antibodies when developing a bioassay and are selected by the Systematic Evolution of Ligands by Exponential Enrichment (SELEX) process. After selection, an extensive characterization process is essential to verify the binding affinity and specificity of aptamer candidates, which is the most time-consuming and costly step. In this study, we assessed a new microfluidic platform, namely Evalution™, as a rapid and high throughput aptamer characterization platform. To do this, we first selected aptamers against influenza A nucleoprotein (infA NP) by performing magnetic bead-based SELEX. The selected aptamer candidates were subsequently screened using Evalution™ for their binding kinetics and specificity towards infA NP. All aptamers showed dissociation constants (K) in the low nanomolar range (from 13 to 41 nM), and differential binding behavior towards control proteins, such as BSA and influenza B nucleoprotein (infB NP). Among 5 selected candidates, one aptamer (NP5) exhibited a significant discrimination between infA NP and infB NP and was further used to benchmark the kinetic analysis of Evalution™ (K = 41 nM) with an SPR platform (K = 17 nM). These results suggested that NP5 has the potential to be used for developing sensitive and infA NP specific aptamer-based assay. Moreover, the presented platform proved to be an efficient aptamer characterization tool for performing typical aptamer characterization experiments like binding kinetics (due to the real-time monitoring feature) and specificity assessment in a high-throughput manner due to the multiplexing capacity.

摘要

适体作为生物测定开发中抗体的替代生物受体具有很大的优势,通过指数富集的配体系统进化(SELEX)过程进行选择。选择后,必须进行广泛的表征过程来验证适体候选物的结合亲和力和特异性,这是最耗时和最昂贵的步骤。在这项研究中,我们评估了一种新的微流控平台,即 Evalution™,作为一种快速和高通量的适体表征平台。为此,我们首先通过基于磁珠的 SELEX 选择针对流感 A 核蛋白(infA NP)的适体。随后,使用 Evalution™ 筛选选定的适体候选物,以评估其与 infA NP 的结合动力学和特异性。所有适体的解离常数(K)均在纳摩尔范围内(从 13 到 41 nM),并且对对照蛋白(如 BSA 和流感 B 核蛋白(infB NP))表现出不同的结合行为。在 5 个选定的候选物中,一个适体(NP5)在 infA NP 和 infB NP 之间表现出显著的区分,并进一步用于基准测试 Evalution™ 的动力学分析(K=41 nM)与 SPR 平台(K=17 nM)。这些结果表明,NP5 有可能被用于开发灵敏且特异性针对 infA NP 的适体基测定法。此外,该平台被证明是一种高效的适体表征工具,可用于以高通量方式进行典型的适体表征实验,如结合动力学(由于实时监测功能)和特异性评估,由于其多重检测能力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验